TerminatedPhase 2NCT03746587

Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3

Studying Gaucher disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ZevraDenmark
Principal Investigator
Aabha Nagral, MD
Jaslok Hospital and Reseach Centre, Mumbai
Intervention
Arimoclomol(drug)
Enrollment
39 enrolled
Eligibility
4-60 years · All sexes
Timeline
2018 – 2021

Study locations (8)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03746587 on ClinicalTrials.gov

Other trials for Gaucher disease

Additional recruiting or active studies for the same condition.

See all trials for Gaucher disease →

← Back to all trials